YPSOMED HOLDING AG Ypsomed Holding AG Share Price
Equities
YPSN
CH0019396990
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 337.5 CHF | -0.44% |
|
-11.18% | +11.39% |
| 16/04 | Ypsomed Partners with ten23 health for Wearable Injector Product Commercialization | MT |
| 12/04 | Dental Equipment Company Straumann Names New Chair | MT |
| Sales 2024 * | 555M 607M 50.66B | Sales 2025 * | 661M 722M 60.32B | Capitalization | 4.61B 5.04B 421B |
|---|---|---|---|---|---|
| Net income 2024 * | 76M 83.1M 6.94B | Net income 2025 * | 99M 108M 9.04B | EV / Sales 2024 * | 8.68 x |
| Net Debt 2024 * | 212M 232M 19.39B | Net Debt 2025 * | 286M 313M 26.11B | EV / Sales 2025 * | 7.41 x |
| P/E ratio 2024 * |
60.7
x | P/E ratio 2025 * |
43.6
x | Employees | 2,200 |
| Yield 2024 * |
0.47% | Yield 2025 * |
0.68% | Free-Float | 26.09% |
More Fundamentals
* Assessed data
More news
Latest transcript on Ypsomed Holding AG
More recommendations
More press releases
| 1 day | -0.44% | ||
| 1 week | -11.18% | ||
| Current month | -6.38% | ||
| 1 month | -5.99% | ||
| 3 months | +12.13% | ||
| 6 months | +35.54% | ||
| Current year | +11.39% |
1 week
334.50
377.50
1 month
334.50389.50
Current year
287.50389.50
1 year
203.00389.50
3 years
121.60389.50
5 years
102.40389.50
10 years
76.10389.50
| Managers | Title | Age | Since |
|---|---|---|---|
Simon Michel
CEO | Chief Executive Officer | 47 | 01/06/01 |
Frank Mengis
COO | Chief Operating Officer | 60 | 01/15/01 |
Thomas Kutt
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Paul R. Fonteyne
BRD | Director/Board Member | 63 | 01/18/01 |
| Director/Board Member | 54 | 01/19/01 | |
| Chairman | 60 | 01/20/01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 10 M€ | -3.35% | - | |
| 0.01% | 773 M€ | -.--% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 337.5 | -0.44% | 20,107 |
| 25/24/25 | 339 | -5.57% | 18,891 |
| 24/24/24 | 359 | -1.64% | 27,687 |
| 23/24/23 | 365 | -0.14% | 19,304 |
| 22/24/22 | 365.5 | -3.82% | 21,428 |
Delayed Quote Swiss Exchange, April 26, 2024 at 09:01 pm IST
More quotes
Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.
Calendar
22/05/2024
- Q4 2024 Earnings Call
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
337.5
CHF
Average target price
351.3
CHF
Spread / Average Target
+4.10%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +11.39% | 5.04B | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.07% | 26.48B | |
| +2.36% | 26.25B | |
| +12.96% | 24.62B |
- Stock Market
- Equities
- YPSN Stock
